HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$16.98
Day range
$16.85 - $17.42
Year range
$7.88 - $17.43
Market cap
8.49B USD
Avg Volume
4.88M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.20B | -4.14% |
Operating expense | 557.00M | 2.77% |
Net income | 32.00M | -68.93% |
Net profit margin | 2.66 | -67.52% |
Earnings per share | 0.34 | -24.44% |
EBITDA | 299.00M | -24.11% |
Effective tax rate | -166.67% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 345.00M | 5.83% |
Total assets | 14.02B | -11.10% |
Total liabilities | 7.96B | -3.93% |
Total equity | 6.06B | — |
Shares outstanding | 494.18M | — |
Price to book | 1.38 | — |
Return on assets | 2.34% | — |
Return on capital | 2.78% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 32.00M | -68.93% |
Cash from operations | 2.00M | 101.38% |
Cash from investing | 37.00M | 167.27% |
Cash from financing | -27.00M | -115.52% |
Net change in cash | -7.00M | 74.07% |
Free cash flow | -432.12M | -235.31% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,550